Treating ovarian cancer with anti-angiogenic agents

Ovacome shares videos from its Staying Connected webinars. Click here to watch the webinar on current research into treating ovarian cancer with anti-angiogenic agents, such as a bevacizumab, presented by Professor Gordon Jayson, BM, BA, Bch, FRCP, PhD, professor of oncology at The Christie in Manchester, England.